The Worldwide GMP Testing Service Industry is Expected to Reach $7.4 Billion by 2031

titled, "GMP Testing Service Market by Service Type (Product Validation Testing, Bioanalytical Services, Packaging and Shelf-Life Testing, Others), by End User (Pharmaceutical and Biopharmaceutical Companies, Medical Device Companies): Global Opportunity Analysis and Industry Forecast, 2021-2031." According to the report, the global GMP testing service industry generated $1.3 billion in 2021, and is expected to reach $2.5 billion by 2031, witnessing a CAGR of 6.7% from 2022 to 2031.

Download Sample PDF at: https://www.alliedmarketresearch.com/request-sample/17356 

Drivers, Restraints and Opportunities

Surge in usage of bioanalytical testing outsourcing services for drug development & validation and the development of biosimilars, combination products, and other medicines that raised the demand for specific testing procedures drive the growth of the global GMP testing service market. However, lack of stringent regulatory framework related to outsourcing of GMP testing services hinders the market growth. On the other hand, increase in adoption of GMP testing services in R&D activities present new opportunities in the coming years.

Covid-19 Scenario

  • Owing to rise in new drug development activities to combat the Covid-19 pandemic, the adoption of GMP testing service increased considerably. This led to surge in the revenue of GMP testing services.
  • The ban on import-export activities by many countries hindered the market growth during the pandemic as the supply chain disrupted and raw material shortage occurred.

The product validation testing segment contributed to the highest share in 2021

Based on service type, the product validation testing segment contributed to the highest market share in 2021, contributing to more than one-third of the global GMP testing service market. This is attributed to rise in number of drugs manufacturing plants and increase in demand for improved quality and safe management of service. However, the bioanalytical services segment is expected to manifest the fastest CAGR of 7.9% from 2022 to 2031, owing to surge in various types of bioanalytical services for testing the drugs.

Specific Requirement on COVID-19? Ask to Our Industry Expert: https://www.alliedmarketresearch.com/request-for-customization/17356?reqfor=covid

The pharmaceutical and biopharmaceutical companies segment to maintain its leadership status by 2031

Based on end user, the pharmaceutical and biopharmaceutical companies segment held the highest share in 2021, accounting for more than two-thirds of the global GMP testing service market, and is projected to maintain its leadership status by 2031. Moreover, this segment is projected to witness the highest CAGR of 7.4% from 2022 to 2031. This is due to rise in innovation activities and new service development along with increase in large number of key players. The report also analyzes the medical device companies segment.

North America to continue its lead position by 2031

Based on region, North America contributed to the highest market share in terms of revenue in 2021, accounting for more than two-fifths of the global GMP testing service market, and is projected to continue its lead position by 2031. This is attributed to robust infrastructure provided to carry out research activities and the presence of leading players in this region. However, Asia-Pacific is estimated to witness the largest CAGR of 9.0% during the forecast period. This is due to increase in utilization of GMP testing services in the pharmaceutical sector, surge in R&D activities for launching new products, and rise in investments in the healthcare sector.

Leading Market Players

  • Almac Group
  • Charles River Laboratory
  • Intertek Group PLC
  • Merck KgaA
  • Eurofins Scientific
  • Nelson Laboratories
  • Wuxi App Tec
  • Sartorius AG
  • Icon Inc.
  • Microchem Laboratory

Comments

Post a Comment

Popular posts from this blog

$1,082.44+ Million Breast Biopsy Market key highlights driving the industry CAGR of 5.1% Forecast, 2024-2030

Image
  The global  breast biopsy market , valued at $658.17 million in 2020, is projected to reach $1,082.44 million by 2030, growing at a compound annual growth rate (CAGR) of 5.1%. As breast biopsies play a crucial role in diagnosing breast cancer, advancements in technology, and rising awareness, the market is experiencing steady growth. Below are some of the key highlights driving the industry: 𝐆𝐞𝐭 𝐚 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐭𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭:  https://www.alliedmarketresearch.com/request-sample/1067 1. Breast Biopsy: A Diagnostic Tool Breast biopsies are essential for diagnosing breast cancer and identifying other conditions through physical examinations. The most common method is fine needle aspiration biopsy (FNAB), a minimally invasive procedure that leaves no scarring. Additionally, ultrasound-guided biopsies use real-time imaging to locate tissue, while stereotactic mammography uses images from various angles to precisely guide the needle. 2. High Efficacy ...
Read more

The Future of Cell Culture Media Market Growth, Trends, and Opportunities (2025-2035)

  The global  cell culture media market , valued at $5.2 billion in 2023, is projected to surge to $17.6 billion by 2035, growing at a CAGR of 10.7% from 2024 to 2035. This exponential growth is fueled by rising demand for biopharmaceuticals, vaccines, and gene therapies, driven by increasing cases of cancer, autoimmune disorders, and infectious diseases. Get a Sample Copy of this Report:  https://www.alliedmarketresearch.com/request-sample/A47229
Read more

The Surging Demand for Surgical Masks in India: Trends, Challenges, and Opportunities

  https:// www.alliedmarketresearch.com/surgical-mask-market Surgical masks have become an essential component of healthcare and personal hygiene, playing a crucial role in infection control. In India, the surgical mask market has seen exponential growth, fueled by increased healthcare awareness, rising surgical procedures, and pandemic-induced demand. The market, valued at $71.73 million in 2019, is projected to reach $157.13 million by 2027, growing at a CAGR of 10.3%. Get a Sample Copy of this Report:  https://www.alliedmarketresearch.com/request-sample/5125 Key Growth Drivers 1. Rising Surgical Procedures • India has a high prevalence of infectious diseases, neonatal disorders, and non-communicable diseases, leading to an increased number of surgical interventions. • The growing number of surgeries has directly boosted demand for surgical masks and other disposable protective gear. 2. Increasing Awareness of Hospital-Acquired Infections (HAIs) • HAIs pose a significant thr...
Read more